Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245228 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL564247 | 1.00 | — | — | |
| SCHEMBL9983408 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL5855710 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL25185965 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL11169476 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL25185997 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL969106 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6297425 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL3212632 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111205282-B | ER protein modulators and uses thereof | 上海科技大学 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-20220016102-A1 | ER PROTEIN REGULATORS AND USE THEREOF | SHANGHAITECH UNIVERSITY (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-2485289-B1 | LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-2478981-B1 | SILVER-(CONJUGATED COMPOUND) COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| EP-2605621-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD OF PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-07-15 | — | — | EP | disclosed |
| CN-111205282-A | ER protein modulators and uses thereof | 上海科技大学 | 2020-05-29 | — | — | CN | disclosed |
| EP-2846374-B1 | Layered structure | SUMITOMO CHEMICAL CO (JP) | 2019-11-06 | — | — | EP | disclosed |
| CN-1163224-C | Medicine for improving excretion capacity of bladder | ����ҩƷ��ҵ��ʽ���� | 2004-08-25 | — | — | CN | disclosed |
| CN-1328451-A | Medicine for improving excretion capacity of bladder | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-12-26 | — | — | CN | disclosed |
| EP-0696585-B1 | NOVEL BISOXADIAZOLIDINE DERIVATIVE | YAMANOUCHI PHARMA CO LTD (JP) | 1998-12-16 | — | — | EP | disclosed |
| US-5643931-A | ANTIDIABETIC AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0696585-A1 | NOVEL BISOXADIAZOLIDINE DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1996-02-14 | — | — | EP | disclosed |
| US-5039674-A | Calcium antagonistics | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-08-13 | — | — | US | disclosed |
| US-4782160-A | CALCIUM RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| EP-0276552-A1 | 1,4-dihydropyridine derivatives and their production | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-03 | — | — | EP | disclosed |
| US-RE31522-E | COPOLYMERS OF DIAMINE-ENDCAPPED POLYOXYETHYLENE GLYCOLS AND A DICARBOXYLIC ACID; HYDRAULIC FLUIDS; METAL WORKING | CINCINNATI MILACRON INC. (US) | 1984-02-14 | — | — | US | disclosed |
| US-4374741-A | LUBRICANTS, METAL WORKING, POLYETHER BLOCK POLYMERJ | CINCINNATI MILACRON INC. (US) | 1983-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016102-A1 | ER PROTEIN REGULATORS AND USE THEREOF | ESR2, ESRRG, ESRRA | TSHR 2221/4885THRB 946/4885FAAH 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.